adap price target

Adaptimmune Therapeutics has a 52 week low of $2.00 and a 52 week high of $13.40. Insider Monkey +6.88%. $52.04. Many experts also interview Adaptimmune Ther executives and customers to further validate their buy or sell advice. Estimates (3) Low: Projected EPS: High-0.94-0.9-0.86: Details. Ergobaby Omni 360 All Carry Positions Ergonomic Baby Carrier - Pure Black. On top of this, the average price target is $13.33, suggesting robust growth of ~236% from the current price of $3.97. ADAP has a greater number of analysts covering the stock than 77.88% of stocks in the small market cap category. Their average twelve-month price target is $15.50, suggesting a possible upside of 162.7%. Market Behavior Value stocks sell-off for large cap. The projected low price target is $6 while the price target rests at a high of $17. Free trial. 2.00. TipRanks lets you see the track record and measured performance of any analyst or blogger you come across, so you know who to trust! Further, Adaptimmune Therapeutics plc (ADAP) has a beta value of 2.21, and an average true range (ATR) of 0.45. ADAP has a greater average analyst price target than 23.84% of all US stocks. The analyst firm set a price target for 6.00 expecting ADAP to … 13.40. 5.4735-0.2565 (-4.48%) Upgrade to Real-Time Regular Market . You may find the need to stake your target base depending on the distance and calibers used as well as the plate size. for only . The average price target for the stock over the next 12 months is $11.33, with the estimates having a low of $6 and a high of $17. The average price target is $8.00 with a high forecast of $8.00 and a low forecast of $8.00. Follow ADAP. The Average True Range (ATR) for Adaptimmune Therapeutics plc is set at 0.35, with the Price to Sales ratio for ADAP stock in the period of the last 12 months amounting to 195.91. The average price target is $160.57 with a high forecast of $225.00 and a low forecast of $103.00.The average price target represents a 24.20% increase from the last price of $129.28. You can unlock it all now. Ergobaby. Best deals to access real time data! See low price in cart . 06:09 AM ET. See low price in cart. $139.99 . Adaptimmune Therapeutics shares are trading higher after Baker Bros. Advisors reported a 6.4% passive stake in the company. Your current $100 investment may be up to $153.43 in 2026. They currently have an outperform rating on the biotechnology company’s stock. The analyst firm set a price target for 6.00 expecting ADAP to rise to within 12 months (a possible 14.50% upside). Adaptimmune Therapeutics reported earnings per share … The stock price for Adaptimmune Therapeutics (NASDAQ: ADAP) is $5.24 last updated Today at 6:41:57 PM. Its programs include MAGE-A10 T-cell therapy, NON-SMALL CELL LUNG CANCER, AFP SPEAR T-cell, MAGE-A4 SPEAR T-cell therapy and NY-ESO SPEAR T-cell for multiple cancer types. ADAP updated stock price target summary. ADI Target Price. These price ends are -11.11% and +151.85% off the current price level respectively, although investors could be excited at the prospect of a +77.78% if the ADAP share price touches on the median price of $12. Monday, June 01, 2020. Small Cap Basic. … See the POWR Ratings now! Ergobaby. Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States. Earnings. Correlated ETFs: Broad market will support ADAP decline at-1.3% a week (61% probability) URA(66%) EWJ(62%) XBI(60%) LIT(59%) IWM(57%) Factors Impacting ADAP price Volatility 8.26 % Daily Average Volatility. Based on 5 analysts offering 12 month price targets for Kadmon Holdings in the last 3 months. Over the past six months, the relative strength of its shares against the market has been -26.92%. volume What is stop-loss? Morgan Stanley has the highest price target set, predicting ADAP will reach $42.00 in the next twelve months. $139.99 - $140.00. Free trial. Two analysts have made estimates for Adaptimmune Therapeutics’ earnings, with the highest EPS estimate coming in at ($0.19) and the lowest estimate coming in at ($0.27). Earnings. Adaptimmune Therapeutics plc (NASDAQ:ADAP) CEO Adrian Rawcliffe Sells 9,879 Shares. Adaptimmune Therapeutics price target cut to $9 from $12 at SunTrust Robinson Humphrey Rotation from value to growth for small cap. 4.6 out of 5 stars with 744 reviews. Join. Based on analysts offering 12 month price targets for ADAP in the last 3 months. Find real-time ADAP - Adaptimmune Therapeutics PLC stock quotes, company profile, news and forecasts from CNN Business. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Please note, it is not enough to conduct a financial or market analysis of a single entity such as Adaptimmune Ther. The transaction was disclosed in a filing with the SEC, which is accessible … Average Share Price and Price Target by Month. Simply Wall St. Dec-16-20 12:32PM : Is ADAP A Good Stock To Buy Now? Choose options. Target features the Thoracic Cavity or center of vital mass, the Cranial Ocular Cavity for immediate incapacitation, Trigger Diagnostic Wheel, Trigger Speed Bar, Shapes, Colors, and Numbers for reactive call-out drills. 173. Adaptimmune Therapeutics’s Q1 earnings are confirmed from now on May 13, 2021. Simply Wall St. Nov-20-20 07:30AM : Adaptimmune to Showcase Market Potential for SPEAR T-cell … Adaptimmune Therapeutics Share Price - ADAP . Support & Resistance Resistance: $5.77 Price: $5.01 Support: $4.91. In depth view into Adaptimmune Therapeutics Price Target including historical data from 2015, charts, stats and industry comps. On November 05, 2020 "SVB Leerink" gave "Market Perform" rating for ADAP. The price target was set to $10.00 → $6.00. During the day the stock fluctuated 7.29% from a day low at $5.35 to a day high of $5.74. Adapt IT Holdings Stock Forecast, ADI stock price prediction. Adaptimmune Therapeutics (NASDAQ:ADAP) had its target price reduced by Raymond James from $16.00 to $6.00 in a report published on Tuesday, May 7th, The Fly reports. Login Choose options. Delayed Data. Other companies in Adaptimmune Therapeutics’s space includes: KalVista Pharmaceuticals (NASDAQ:KALV), Avidity Biosciences (NASDAQ:RNA) and Curis (NASDAQ:CRIS).

Indeed Richmond, Va, Dr Owen Hunt, Best Takeaway Dublin Lockdown, Ramadan 2020 Kazakhstan, Blackout Curtain Meaning, Global Jet Cabin Crew Salary, Face Mask With Dog Design,